Cargando…
546. Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19
BACKGROUND: CURE ID is an internet-based repository developed collaboratively by FDA and NCATS/NIH, with the support of WHO and IDSA. It encourages clinicians globally to share novel uses of existing drugs for patients with difficult-to-treat infections. It is designed to serve as a rapid communicat...
Autores principales: | Duggal, Mili, Stone, Heather, Paul, Parvesh, Charles, Reema, Sacks, Leonard, Southall, Noel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777160/ http://dx.doi.org/10.1093/ofid/ofaa439.740 |
Ejemplares similares
-
Collaborative Use Repurposing Engine (CURE): FDA-NCATS/NIH Effort to Capture the Global Clinical Experience of Drug Repurposing to Facilitate Development of New Treatments for Neglected and Emerging Infectious Diseases
por: Stone, Heather, et al.
Publicado: (2017) -
1380. Safety of Repurposed Drugs for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: An Analysis of Adverse Events Reported in the Literature
por: Stone, Heather, et al.
Publicado: (2019) -
627. CURE ID as a Tool for Curating and Analyzing Drugs Used in COVID-19 Clinical Trials
por: Charles, Reema, et al.
Publicado: (2021) -
546. No Difference in MK-8591 and Doravirine Pharmacokinetics After Co-Administration
por: Matthews, Randolph, et al.
Publicado: (2018) -
P546: MACHINE LEARNING AND RESPONSE TO INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Elhaddad, Heba, et al.
Publicado: (2023)